Showing results (61-70 of 108) with videos related to
Sort By:
Pageof 11
Leukemia & Lymphoma|July 12, 2017
Prognostic impact of incomplete hematologic count recovery and minimal residual disease on outcome in adult acute lymphoblastic leukemia at the time of second complete responseCaner Saygin, Nikolaos Papadantonakis, Ryan D Cassaday, et al.Scientific Reports|March 29, 2020
Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemiaAndrew P Michelson, Shannon McDonough, Cheryl L Willman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2017
Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid CancerRemco J Molenaar, Surbhi Sidana, Tomas Radivoyevitch, et al.Clinical Lymphoma, Myeloma & Leukemia|December 16, 2010
A Phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapseAnjali S Advani, Mazyar Shadman, Francis Ali-Osman, et al.Cancer|November 24, 2020
Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome-positive relapsed/refractory acute lymphoblastic leukemiaWendy Stock, Giovanni Martinelli, Matthias Stelljes, et al.Blood|August 24, 2012
Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromesMikkael A Sekeres, Ramon V Tiu, Rami Komrokji, et al.Blood Advances|July 15, 2022
Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemiaLori Muffly, Jun Yin, Sawyer Jacobson, et al.Blood Advances|November 2, 2022
Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemiaAnjali S Advani, Anna Moseley, Kristen M O'Dwyer, et al.Blood Advances|October 21, 2022
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 studyIbrahim Aldoss, Jun Yin, Anna Wall, et al.Leukemia & Lymphoma|April 9, 2025
Impact of TP53 mutation on survival outcomes in acute lymphoblastic leukemia at a tertiary centerMeera Patel, Emily C Zabor, Ahmed Mohamed, et al.Pageof 11